Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease

OBJECTIVE: Incident type 2 diabetes is common among patients with recent acute coronary syndrome and is associated with an adverse prognosis. Some data suggest that cholesteryl ester transfer protein (CETP) inhibitors reduce incident type 2 diabetes. We compared the effect of treatment with the CETP...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Diabetes Care
Hlavní autoři: Schwartz, Gregory G., Leiter, Lawrence A., Ballantyne, Christie M., Barter, Philip J., Black, Donald M., Kallend, David, Laghrissi-Thode, Fouzia, Leitersdorf, Eran, McMurray, John J.V., Nicholls, Stephen J., Olsson, Anders G., Preiss, David, Shah, Prediman K., Tardif, Jean-Claude, Kittelson, John
Médium: Artigo
Jazyk:Inglês
Vydáno: American Diabetes Association 2020
Témata:
Emerging Therapies: Drugs and Regimens
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7171952/
https://ncbi.nlm.nih.gov/pubmed/32144166
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc19-2204
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky